Rituximab in Membranous Nephropathy
Open Access
- 13 January 2021
- journal article
- review article
- Published by Elsevier BV in Kidney International Reports
- Vol. 6 (4), 881-893
- https://doi.org/10.1016/j.ekir.2020.12.035
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Rituximab for the second- and thirdline therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategyClinical Nephrology, 2013
- Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trialThe Lancet, 2013
- Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 PatientsNephron Extra, 2011
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Arthritis Research & Therapy, 2011
- Rituximab Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyThe New England Journal of Medicine, 2009
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent PatientsClinical Journal of the American Society of Nephrology, 2009
- Effects of Rituximab on Morphofunctional Abnormalities of Membranous GlomerulopathyClinical Journal of the American Society of Nephrology, 2008
- Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2007
- A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous NephropathyAmerican Journal of Kidney Diseases, 2006